Spreading depression-induced preconditioning in the mouse cortex: differential changes in the protein expression of ionotropic nicotinic acetylcholine and glutamate receptors

被引:18
作者
Chazot, PL [1 ]
Godukhin, OV
McDonald, A
Obrenovitch, TP
机构
[1] Univ Sunderland, Inst Pharm Chem & Biomed Sci, Sch Hlth Nat & Social Sci, Sunderland SR2 3SD, Tyne & Wear, England
[2] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
关键词
cortical spreading depression; glutamate receptors; ischaemia; neuroprotection; nicotinic acetylcholine receptors; preconditioning;
D O I
10.1046/j.1471-4159.2002.01240.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preconditioning of the cerebral cortex was induced in mice by repeated cortical spreading depression (CSD), and the major ionotropic glutamate (GluRs) and nicotinic acetylcholine receptor (nAChRs) subunits were compared by quantitative immunoblotting. between sham- and preconditioned cortex, 24 h after treatment. A 30% reduction in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) GluR1 and 2 subunit immunoreactivities was observed in the preconditioned cortex (p < 0.03), but there was no significant change in the NMDA receptor subunits, NR1, NR2A and NR2B. A 12-15-fold increase in α7 nAChR subunit expression following in vivo CSD (p < 0.001) was by far the most remarkable. change associated with preconditioning. In contrast, the alpha4 nAChR subunit was not altered. These data point to the alpha7 nAChR as a potential new target for neuroprotection because preconditioning increases consistently, the tolerance of the brain to acute insults such as ischaemia. These data complement recent studies implicating alpha7 nAChR overexpression in the amelioration of chronic neuropathologies, notably Alzheimers disease (AD).
引用
收藏
页码:1235 / 1238
页数:4
相关论文
共 37 条
[1]  
Arroyo-Jiménez MD, 1999, J NEUROSCI, V19, P6475
[2]   Central nicotinic receptors, neurotrophic factors and neuroprotection [J].
Belluardo, N ;
Mudò, G ;
Blum, M ;
Fuxe, K .
BEHAVIOURAL BRAIN RESEARCH, 2000, 113 (1-2) :21-34
[3]   Phorbol ester activation of the neuronal nicotinic acetylcholine receptor α7 sub-unit gene:: Involvement of transcription factor Egr-1 [J].
Carrasco-Serrano, C ;
Viniegra, S ;
Ballesta, JJ ;
Criado, M .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (03) :932-939
[4]   Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists [J].
Chazot, PL ;
Lawrence, S ;
Thompson, CL .
NEUROPHARMACOLOGY, 2002, 42 (03) :319-324
[5]   EVIDENCE FOR THE INVOLVEMENT OF A CARBOXYL GROUP IN THE VICINITY OF THE MK801 AND MAGNESIUM-ION BINDING-SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR [J].
CHAZOT, PL ;
FOTHERBY, A ;
STEPHENSON, FA .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (03) :605-610
[6]  
CHAZOT PL, 1998, IMMUNOPRECIPITATION, V33, pCH12
[7]   The α7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca2+ dependent mechanism [J].
Dajas-Bailador, FA ;
Lima, PA ;
Wonnacott, S .
NEUROPHARMACOLOGY, 2000, 39 (13) :2799-2807
[8]   Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus [J].
Fabian-Fine, R ;
Skehel, P ;
Errington, ML ;
Davies, HA ;
Sher, E ;
Stewart, MG ;
Fine, A .
JOURNAL OF NEUROSCIENCE, 2001, 21 (20) :7993-8003
[9]   Asymmetric propagation of spreading depression along the anteroposterior axis of the cerebral cortex in mice [J].
Godukhin, OV ;
Obrenovitch, TP .
JOURNAL OF NEUROPHYSIOLOGY, 2001, 86 (04) :2109-2111
[10]  
GODUKHIN OV, 2002, FENS ABSTR, V1